Your Messages Inbox
Your Article Summary
See Latest ArticlesNexavar in Combination with Chemotherapy Shown To Extend Progression-Free Survival in Patients with Advanced Breast Cancer
BayNews International, 08/17/09
The study evaluated Nexavar tablets in combination with the oral chemotherapeutic, capecitabine, in patients with locally advanced or metastatic HER–2 negative breast cancer. Study findings demonstrated that the median progression–free survival was extended in patients treated with Nexavar and capecitabine compared to patients receiving capecitabine and placebo. These results were statistically significant. In this trial, the safety and tolerability of the combination was as expected and did not show any new or unexpected toxicities. A complete data analysis from this study is expected to be presented at an upcoming scientific meeting.
Today in Conferences/Meetings...keeping you current
Receive free subspecialty "5-minute updates" via email
ONC to Explain Community I.T. Project
HealthDataManagement, 12/17/09
Covidien plc to Report First-Quarter Results on January 2010
Covidien, 12/17/09
MediGene AG presents future business plan at annual analyst conference
MediGene, 12/16/09
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
Milatuzumab – a promising new immunotherapeutic agent
Expert Opinion on Investigational Drugs, 12/17/09
Association of trial registration with the results and conclusions of published trials of new oncology drugs
Trials, 12/17/09
Prognostic Factors in Idiopathic Pulmonary Fibrosis
The American Journal of the Medical Sciences, 12/17/09
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
deCODE Discovers A Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin
deCODE genetics, 12/17/09
The Medtronic Foundation Offers Grants to Schools Participating in Online Sudden Cardiac Arrest Response Training
Medtronic, 12/17/09
AstraZeneca and the University of Virginia sign strategic research collaboration to develop novel treatments for cardiovascular disease
AstraZeneca, 12/16/09
Article Search
Sponsor